39929-79-8

Basic information

• Product Name: 7H-Pyrrolo[2,3-d]pyrimidine-2,4-diol
• Synonyms: 1H-PYRROLO-[2,3-D]-PYRIMIDINE-2,4(3H,7H)-DIONE;1,7-DIHYDRO-PYRROLO[2,3-D]PYRIMIDINE-2,4-DIONE;2,4-Dihydroxy-1H-pyrrolo[2,3-d]pyrimidine;2,4-Dihydroxy-7-deazapurine;7H-Pyrrolo[2,3-d]pyrimidine-2,4-diol;4,6-DIHYDROXY PYRROLO PYRIMIDINE;2,4-Dihydroxy-7H-pyrrolo-(2,3-d)pyrimidine;2,4-Dihydroxy-7H-pyrrolo[2,3-d]pyrimidine, 2,6-Dihydroxy-7-deazapurine
• CAS NO: 39929-79-8
• Molecular Formula: C₆H₅N₃O₂
• Molecular Weight: 151.12
• Product Categories: Nucleotides and Nucleosides;Bases & Related Reagents;Intermediates;Nucleotides;Fused Ring Systems;Heterocycle-Pyrimidine series
• Mol File: 39929-79-8.mol
• Article Data: 21

Chemical Properties

• Melting Point: >250°C
• Appearance: Pink to brown solid
• Density: 1.774 g/cm³
• Refractive Index: 1.863
• Storage Temp.: -20°C Freezer
• PKA: 11.22±0.20(Predicted)
• CAS DataBase Reference: 7H-Pyrrolo[2,3-d]pyrimidine-2,4-diol(CAS DataBase Reference)
• NIST Chemistry Reference: 7H-Pyrrolo[2,3-d]pyrimidine-2,4-diol(39929-79-8)
• EPA Substance Registry System: 7H-Pyrrolo[2,3-d]pyrimidine-2,4-diol(39929-79-8)

Safety Data

• Hazard Codes: Xi
• Hazardous Substances Data: 39929-79-8(Hazardous Substances Data)

Usage

Uses

2,4-Dihydroxypyrrolo[2,3-d]pyrimidine (cas# 39929-79-8) is a compound useful in organic synthesis.

InChI:InChI=1/C6H5N3O2/c10-5-3-1-2-7-4(3)8-6(11)9-5/h1-2H,(H3,7,8,9,10,11)

Upstream product

• 52133-67-2 ethyl 2-cyano-4,4-diethoxybutyrate 
• 57-13-6 urea 
• 107-20-0 2-chloroethanal 
• 873-83-6 6-amino-2,4-dihydroxypyrimidine 
• 873-83-6 4-Amino-2,6-dihydroxypyrimidine 
• 3680-71-5 7-deazahypoxanthine 
• 271-70-5 7H-pyrrolo[2,3-d]pyrimidine 
• 90057-09-3 2,4-dimethoxy-7H-pyrrolo<2,3-d>pyrimidine 
• 102879-75-4 4-Amino-2,6-dihydroxy-5-(2,2-diethoxy-ethyl)-pyrimidin 

Downstream Products

• 1245811-22-6 2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-ol 
• 1245811-24-8 2-((2-chloro-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-3-yl)methyl)benzonitrile 
• 1377432-82-0 2-((2-chloro-7-methyl-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-3-yl)methyl)benzonitrile 
• 1245810-97-2 2-((2-((R)-3-aminopiperidin-1-yl)-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-3-yl)methyl)benzonitrile 
• 1245811-15-7 2-((2-((R)-3-aminopiperidin-1-yl)-7-methyl-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-3-yl)methyl)benzonitrile 
• 1377432-83-1 tert-butyl ((3R)-1-(3-(2-cyanobenzyl)-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-2-yl)piperidin-3-yl)carbamate 
• 1377432-85-3 tert-butyl ((3R)-1-(3-(2-cyanobenzyl)-7-methyl-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-2-yl)piperidin-3-yl)carbamate 
• 1377432-86-4 tert-butyl ((3R)-1-(6-bromo-3-(2-cyanobenzyl)-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-2-yl)piperidin-3-yl)carbamate 
• 1377432-87-5 tert-butyl ((3R)-1-(3-(2-cyanobenzyl)-4-oxo-6-(4-(trifluoromethyl)phenyl)-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-2-yl)piperidin-3-yl)carbamate 
• 1377432-88-6 tert-butyl ((3R)-1-(3-(2-cyanobenzyl)-6-(4-fluorophenyl)-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-2-yl)piperidin-3-yl)carbamate 
• 1377432-89-7 tert-butyl ((3R)-1-(3-(2-cyanobenzyl)-4-oxo-6-(pyridin-3-yl)-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-2-yl)piperidin-3-yl)carbamate 
• 1355173-55-5 2-((2-((R)-3-aminopiperidin-1-yl)-5,6-dibromo-7-methyl-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-3-yl)methyl)benzonitrile 
• 1392847-45-8 C₂₅H₂₈Br₂N₆O₃ 
• 1377432-70-6 2-((2-((R)-3-aminopiperidin-1-yl)-6-bromo-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-3(7H)-yl)methyl)benzonitrile 

Relevant articles and documents

Synthesis and evaluation of FAK inhibitors with a 5-fluoro-7H-pyrrolo[2,3-d]pyrimidine scaffold as anti-hepatocellular carcinoma agents

Focal adhesion kinase (FAK) is a ubiquitous intracellular non-receptor tyrosine kinase, which is involved in multiple cellular functions, including cell adhesion, migration, invasion, survival, and angiogenesis. In this study, a series of 7H-pyrrolo[2,3-d

SUBSTITUTED BICYCLIC PYRIMIDINE-BASED COMPOUNDS AND COMPOSITIONS AND USES THEREOF

Novel C-2-substituted bicyclic compounds of Formula I have been prepared and found to be useful as potent inhibitors of hGGPPS by inhibiting geranylgeranylation of proteins and inhibiting the biosynthesis of GGPP. The application is directed to these compounds, to compositions comprising these compounds, and to their use, in particular as medicaments for use in the treatment of cancer and other conditions which are treatable by inhibiting human geranylgeranylation pyrophosphate hGGPPS activity.

A Anaplastic lymphoma kinase inhibitors (by machine translation)

The present invention of formula (I) compounds, of formula (I) compounds of the type (II) in the middle of the compound, of formula (III) compound and its preparation method. Formula (I) compound is a small molecule Anaplastic lymphoma kinase (Anaplastic